PBE:ARCA-PowerShares Dynamic Biotech &Genome (USD)

ETF | Health | NYSE Arca

Last Closing

USD 67.33

Change

-0.52 (-0.77)%

Market Cap

USD 0.25B

Volume

3.80K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

The investment seeks investment results that generally correspond (before fees and expenses) to the price and yield of the Dynamic Biotech & Genome IntellidexSM Index. The fund generally will invest at least 90% of its total assets in common stocks of biotechnology companies and genome companies that comprise the underlying intellidex. The underlying intellidex was composed of common stocks of 30 U.S. biotechnology and genome companies. These companies are engaged principally in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes, etc. It is non-diversified.

Inception Date: 23/06/2005

Primary Benchmark: Dynamic Biotech&Genome Intellidex TR USD

Primary Index: MSCI ACWI NR USD

Gross Expense Ratio: 0.58%

Management Expense Ratio: 0.57 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-27 )

Largest Industry Peers for Health

Symbol Name Mer Price(Change) Market Cap
XLV Health Care Select Sector SPDR.. 0.13 %

N/A

USD 36.67B
FHLC Fidelity® MSCI Health Care In.. 0.08 %

N/A

USD 2.62B
FXH First Trust Health Care AlphaD.. 0.63 %

N/A

USD 1.09B
XHE SPDR® S&P Health Care Equipme.. 0.35 %

N/A

USD 0.21B
IDNA iShares Genomics Immunology an.. 0.00 %

N/A

USD 0.12B
SBIO ALPS Medical Breakthroughs ETF 0.50 %

N/A

USD 0.11B
XHS SPDR® S&P Health Care Service.. 0.35 %

N/A

USD 0.07B
HTEC Robo Global® Healthcare Techn.. 0.00 %

N/A

USD 0.05B
BBP Virtus LifeSci Biotech Product.. 0.79 %

N/A

USD 0.02B
BBC Virtus LifeSci Biotech Clinica.. 0.79 %

N/A

USD 8.55M

ETFs Containing PBE

WBIR 0.00 % 1.25 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health) Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.26% 43% F 47% F
Dividend Return 0.05% 13% F 1% F
Total Return 2.31% 24% F 34% F
Trailing 12 Months  
Capital Gain 2.26% 43% F 47% F
Dividend Return 0.05% 13% F 1% F
Total Return 2.31% 24% F 34% F
Trailing 5 Years  
Capital Gain 20.19% 48% F 61% D-
Dividend Return 0.13% 11% F N/A F
Total Return 20.32% 43% F 48% F
Average Annual (5 Year Horizon)  
Capital Gain 5.98% 67% D+ 54% F
Dividend Return 5.99% 57% F 47% F
Total Return 0.01% 11% F 2% F
Risk Return Profile  
Volatility (Standard Deviation) 21.01% 48% F 52% F
Risk Adjusted Return 28.50% 52% F 43% F
Market Capitalization 0.25B N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.